Biotech

All Articles

Orion to make use of Aitia's 'electronic doubles' to find brand new cancer cells medications

.Finnish biotech Orion has spied potential in Aitia's "digital double" specialist to establish brand...

Windtree's shock med brings up high blood pressure in newest stage 2 succeed

.While Windtree Therapeutics has actually strained to grow the monetary origins needed to have to en...

2 cancer cells biotechs combine, making international impact

.OncoC4 is actually taking AcroImmune-- and also its own in-house medical production capacities-- un...

Amgen reports 1st stage 3 gain for $400M chronic eczema drug

.Amgen has discussed (PDF) the first period 3 records on its own $400 million eczema medication, lin...

Biogen, UCB record period 3 lupus succeed after neglecting earlier test

.Biogen and also UCB's bank on advancing into stage 3 astride a failed research study looks to have ...

Aptadir wishes brand new RNA inhibitors may turn around difficult cancers cells

.Italian biotech Aptadir Rehabs has actually launched with the pledge that its pipe of preclinical R...

Wave surfs DMD excellence to regulators' doors, sending out stockpile

.Surge Lifestyle Sciences has satisfied its own objective in a Duchenne muscle dystrophy (DMD) resea...

Sanofi plucks brand-new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma crease, tak...

Achilles drips tissue therapy system, braces for layoffs after overlooking 'business viability' goals

.Achilles Rehabs has torn up its own approach. The British biotech is actually quiting working on it...

Aligos advertises phase 2 MASH win, slashing liver body fat up to 46%

.Aligos Therapies is proclaiming a midstage win in metabolic-dysfunction linked steatohepatitis (MAS...